CASH Stock Analysis: Meta Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.755m USD | 12M Return: 7.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.8M
EPS Trend: 90.9%
Qual. Beats: -1
Rev. Trend: 2.0%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pathward Financial, Inc. is a U.S. bank holding company operating through Pathward, National Association, with three reporting segments: Consumer, Commercial, and Corporate Services/Other. Its offerings span demand, savings, and money market deposit accounts, along with a broad commercial finance suite that includes term lending, asset-based lending, factoring, lease financing, insurance premium finance, and government-guaranteed lending. On the consumer side, the company provides installment and revolving lending products, tax-related services such as short-term refund advance loans, and warehouse financing for mortgage originators.
The firm also runs a meaningful payments business, processing credit and debit card transactions, servicing freestanding ATMs, supporting digital payments and merchant services, and issuing its own debit and prepaid cards. Founded in 1954 and headquartered in Sioux Falls, South Dakota, the company was renamed from Meta Financial Group to Pathward Financial in July 2022. As a small-cap regional bank trading on NASDAQ under the ticker CASH, Pathwards mix of niche lending, tax-refund advances, and prepaid card issuance distinguishes it from more traditional deposit-driven regional banks.
- Tax refund advance volume drives seasonal consumer segment swings
- BaaS and prepaid card partnerships accelerate payment solutions revenue
- Net interest margin compresses as Fed rate cuts pressure asset yields
| Net Income: 175.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.63 > 1.0 |
| NWC/Revenue: 283.4% < 20% (prev -704.4%; Δ 987.8% < -1%) |
| CFO/TA 0.09 > 3% & CFO 675.3m > Net Income 175.7m |
| Net Debt (-1.20b) to EBITDA (216.9m): -5.52 < 3 |
| Current Ratio: 8.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.8m) vs 12m ago -5.90% < -2% |
| Gross Margin: 75.28% > 18% (prev 53.82%; Δ 21.47% > 0.5%) |
| Asset Turnover: 6.01% > 50% (prev 9.19%; Δ -3.18% > 0%) |
| Interest Coverage Ratio: 12.09 > 6 (EBIT TTM 202.6m / Interest Expense TTM 16.8m) |
| A: 0.17 (Total Current Assets 1.41b - Total Current Liabilities 167.5m) / Total Assets 7.31b |
| B: 0.05 (Retained Earnings 339.3m / Total Assets 7.31b) |
| C: 0.03 (EBIT TTM 202.6m / Avg Total Assets 7.27b) |
| D: 0.13 (Book Value of Equity 850.9m / Total Liabilities 6.46b) |
| Altman-Z'' = 1.59 = BB |
| DSRI: 0.32 (Receivables 37.0m/174.2m, Revenue 437.0m/664.6m) |
| GMI: 0.71 (GM 53.82% / 75.28%) |
| AQI: 1.04 (AQ_t 0.80 / AQ_t-1 0.77) |
| SGI: 0.66 (Revenue 437.0m / 664.6m) |
| TATA: -0.07 (NI 175.7m - CFO 675.3m) / TA 7.31b) |
| Beneish M = -4.07 (Cap -4..+1) = AAA |
As of July 28, 2026, the stock is trading at USD 86.15 with a total of 244,047 shares traded. Over the past week, the price has changed by -3.57%, over one month by -0.31%, over three months by -2.49% and over the past year by +7.60%.
Current recommended Stop Loss: 78.00 (which is 9.5% or 2.7 ATR below the current price).
Meta Financial has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold CASH.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 107.5 | 24.8% |
P/E Trailing = 10.5349
P/E Forward = 11.236
P/S = 2.2577
P/B = 2.1971
P/EG = 0.2023
Revenue TTM = 437.0m USD
EBIT TTM = 202.6m USD
EBITDA TTM = 216.9m USD
Long Term Debt = 33.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 167.5m USD (from shortTermDebt, last quarter)
Debt = 172.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 5.19m
Net Debt = -1.20b USD (calculated: Debt 172.7m - CCE 1.37b)
Enterprise Value = 558.3m USD (1.75b + Debt 172.7m - CCE 1.37b)
Interest Coverage Ratio = 12.09 (Ebit TTM 202.6m / Interest Expense TTM 16.8m)
EV/FCF = 1.11x (Enterprise Value 558.3m / FCF TTM 502.1m)
FCF Yield = 89.93% (FCF TTM 502.1m / Enterprise Value 558.3m)
FCF Margin = 114.9% (FCF TTM 502.1m / Revenue TTM 437.0m)
Net Margin = 40.20% (Net Income TTM 175.7m / Revenue TTM 437.0m)
Gross Margin = 75.28% ((Revenue TTM 437.0m - Cost of Revenue TTM 108.0m) / Revenue TTM)
Gross Margin QoQ = none% (prev 81.79%)
Tobins Q-Ratio = 0.08 (Enterprise Value 558.3m / Total Assets 7.31b)
Interest Expense / Debt = 9.71% (Interest Expense 16.8m / Debt 172.7m)
Taxrate = 16.02% (33.7m / 210.5m)
NOPAT = 170.2m (EBIT 202.6m * (1 - 16.02%))
Current Ratio = 8.39 (Total Current Assets 1.41b / Total Current Liabilities 167.5m)
Debt / Equity = 0.20 (Debt 172.7m / totalStockholderEquity, last quarter 850.9m)
Debt / EBITDA = -5.52 (Net Debt -1.20b / EBITDA 216.9m)
Debt / FCF = -2.38 (Net Debt -1.20b / FCF TTM 502.1m)
Total Stockholder Equity = 853.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.42% (Net Income 175.7m / Total Assets 7.31b)
RoE = 20.58% (Net Income TTM 175.7m / Total Stockholder Equity 853.7m)
RoCE = 22.84% (EBIT 202.6m / Capital Employed (Equity 853.7m + L.T.Debt 33.5m))
RoIC = 2.33% (NOPAT 170.2m / Invested Capital 7.29b)
WACC = 8.98% (E(1.75b)/V(1.93b) * Re(9.06%) + D(172.7m)/V(1.93b) * Rd(9.71%) * (1-Tc(0.16)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.36 | Cagr: -6.47%
[DCF] Terminal Value 75.96% ; FCFF base≈366.0m ; Y1≈419.5m ; Y5≈617.5m
[DCF] Fair Price = 453.0 (EV 8.37b - Net Debt -1.20b = Equity 9.56b / Shares 21.1m; r=8.98% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.87 | EPS CAGR: 14.46% | SUE: -2.63 | # QB: -1
Revenue Correlation: 2.02 | Revenue CAGR: 0.31% | SUE: -4.0 | # QB: -1
EPS current Quarter (2026-12-31): EPS=1.78 | Chg30d=-1.66% | Revisions=-50% | Analysts=3
EPS current Year (2026-09-30): EPS=8.68 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+18.3% | GrowthRev=-1.7%
EPS next Year (2027-09-30): EPS=9.67 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+11.5% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -22% (up=2, down=4)